$ENSG
ENSIGN GROUP, INC Stock $ensg

$ensg Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000112537622000075 Filed on April 28, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$713.4M	$693.1M	$627.3M
YoY Change	13.74%	10.2%	6.38%
Cost Of Revenue	$555.6M	$531.7M	$482.2M
YoY Change	15.23%	8.36%	6.09%
Gross Profit	$157.8M	$161.4M	$145.1M
YoY Change	8.78%	16.73%	7.38%
Gross Profit Margin	22.12%	23.29%	23.13%
Selling, General & Admin	$79.38M	$81.22M	$71.20M
YoY Change	11.49%	17.88%	5.01%
% of Gross Profit	50.3%	50.31%	49.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.68M	$14.60M	$13.66M
YoY Change	7.45%	8.16%	-0.44%
% of Gross Profit	9.3%	9.05%	9.42%
Operating Expenses	$94.06M	$95.82M	$84.90M
YoY Change	10.79%	16.15%	4.17%
Operating Profit	$69.11M	$65.61M	$63.68M
YoY Change	8.53%	17.59%	12.12%
Interest Expense	$2.068M	-$1.865M	$1.641M
YoY Change	26.02%	273.0%	-55.23%
% of Operating Profit	2.99%	-2.84%	2.58%
Other Income/Expense, Net	-$2.884M	$2.271M	-$893.0K
YoY Change	222.96%		-69.9%
Pretax Income	$66.23M	$66.02M	$62.79M
YoY Change	5.48%	19.17%	16.65%
Income Tax	$16.14M	$17.06M	$12.95M
% Of Pretax Income	24.37%	25.84%	20.62%
Net Earnings	$50.34M	$48.74M	$49.21M
YoY Change	2.3%	5.27%	20.46%
Net Earnings / Revenue	7.06%	7.03%	7.84%
Basic Earnings Per Share	$0.92		$0.91
Diluted Earnings Per Share	$0.89	$857.5K	$0.86
COMMON SHARES
Basic Shares Outstanding	54.67M shares	55.25M shares	54.19M shares
Diluted Shares Outstanding	56.87M shares		56.89M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$260.6M	$276.0M	$170.2M
YoY Change	53.14%	10.39%	117.65%
Cash & Equivalents	$248.5M	$262.2M	$155.5M
Short-Term Investments	$12.09M	$13.76M	$14.60M
Other Short-Term Assets	$32.59M	$35.01M	$30.60M
YoY Change	6.49%	25.5%	19.53%
Inventory
Prepaid Expenses
Receivables	$339.9M	$328.7M	$312.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$633.1M	$639.7M	$513.3M
YoY Change	23.34%	9.74%	18.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$906.8M	$888.4M	$779.3M
YoY Change	16.36%	14.16%	-0.51%
Goodwill	$76.87M	$60.47M	$54.47M
YoY Change	41.12%	11.02%	0.0%
Intangibles
YoY Change
Long-Term Investments	$38.02M	$36.57M	$34.40M
YoY Change	10.53%	13.92%	4.56%
Other Assets	$88.46M	$80.19M	$74.20M
YoY Change	19.21%	22.06%	119.53%
Total Long-Term Assets	$2.411B	$2.211B	$1.999B
YoY Change	20.62%	12.65%	2.28%
TOTAL ASSETS
Total Short-Term Assets	$633.1M	$639.7M	$513.3M
Total Long-Term Assets	$2.411B	$2.211B	$1.999B
Total Assets	$3.045B	$2.851B	$2.513B
YoY Change	21.18%	11.98%	5.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$56.85M	$58.12M	$53.94M
YoY Change	5.39%	14.17%	31.83%
Accrued Expenses	$432.6M	$448.8M	$365.4M
YoY Change	18.39%	14.09%	37.83%
Deferred Revenue	$6.936M	$9.337M	$6.049M
YoY Change	14.66%	9.1%	-2.01%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.723M	$3.760M	$2.828M
YoY Change	31.65%	27.03%	3.7%
Total Short-Term Liabilities	$513.6M	$523.1M	$443.0M
YoY Change	15.92%	-6.99%	34.19%
LONG-TERM LIABILITIES
Long-Term Debt	$152.0M	$152.9M	$111.9M
YoY Change	35.84%	35.9%	-67.53%
Other Long-Term Liabilities	$18.25M	$18.42M	$11.12M
YoY Change	64.15%	65.25%	28.56%
Total Long-Term Liabilities	$18.25M	$18.42M	$11.12M
YoY Change	64.15%	65.25%	28.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$513.6M	$523.1M	$443.0M
Total Long-Term Liabilities	$18.25M	$18.42M	$11.12M
Total Liabilities	$1.973B	$1.829B	$1.637B
YoY Change	20.5%	5.88%	-4.34%
SHAREHOLDERS EQUITY
Retained Earnings	$781.3M	$734.0M	$597.4M
YoY Change	30.79%	33.2%	39.02%
Common Stock	$383.2M	$369.8M	$349.9M
YoY Change	9.53%	9.34%	10.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$92.94M	$83.04M	$71.22M
YoY Change	30.49%	16.61%	1.32%
Treasury Stock Shares	3.077M shares	2.944M shares	2.791M shares
Shareholders Equity	$1.072B	$1.021B	$876.0M
YoY Change
Total Liabilities & Shareholders Equity	$3.045B	$2.851B	$2.513B
YoY Change	21.18%	11.98%	5.21%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	$50.34M	$48.74M	$49.21M
YoY Change	2.3%	5.27%	20.46%
Depreciation, Depletion And Amortization	$14.68M	$14.60M	$13.66M
YoY Change	7.45%	8.16%	-0.44%
Cash From Operating Activities	$45.87M	$71.20M	$34.29M
YoY Change	33.77%	-21.94%	26.44%
INVESTING ACTIVITIES
Capital Expenditures	-$32.85M	-$112.5M	-$15.30M
YoY Change	114.69%	680.96%	-48.83%
Acquisitions	$16.40M		$0.00
YoY Change
Other Investing Activities	-$764.0K	-$3.580M	$279.0K
YoY Change	-373.84%	-183.26%	17.72%
Cash From Investing Activities	-$48.24M	-$116.0M	-$12.21M
YoY Change	295.02%	1037.63%	-21.43%
FINANCING ACTIVITIES
Cash Dividend Paid	$3.035M		$2.868M
YoY Change	5.82%		6.03%
Common Stock Issuance & Retirement, Net	$9.882M		$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$979.0K		$849.0K
YoY Change	15.31%		-99.65%
Cash From Financing Activities	-$11.29M	2.424M	-$103.1M
YoY Change	-89.05%	-112.24%	1267.78%
NET CHANGE
Cash From Operating Activities	$45.87M	71.20M	$34.29M
Cash From Investing Activities	-$48.24M	-116.0M	-$12.21M
Cash From Financing Activities	-$11.29M	2.424M	-$103.1M
Net Change In Cash	-$13.66M	-42.42M	-$81.04M
YoY Change	-83.15%	-169.31%	-2104.82%
FREE CASH FLOW
Cash From Operating Activities	$45.87M	$71.20M	$34.29M
Capital Expenditures	-$32.85M	-$112.5M	-$15.30M
Free Cash Flow	$78.72M	$183.7M	$49.59M
YoY Change	58.73%	73.91%	-13.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001125376
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-33757
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	ENSIGN GROUP, INC
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0861263
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	29222 Rancho Viejo Road, Suite 127
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Juan Capistrano
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92675
CY2022Q1	dei	City Area Code CityAreaCode	949
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	487-9500
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	ENSG
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32586000	USD
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55477077	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	248546000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	262201000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13212000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11213000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	339886000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	328731000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	12093000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	13763000	USD
CY2022Q1	us-gaap	Prepaid Taxes PrepaidTaxes	0	USD
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	5452000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29562000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	633111000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	639709000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	906777000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	888434000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1294931000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1138872000	USD
CY2022Q1	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	38024000	USD
CY2021Q4	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	36567000	USD
CY2022Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	400000	USD
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	32883000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	33147000	USD
CY2022Q1	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	55172000	USD
CY2021Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	47046000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2665000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2652000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	76869000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	60469000	USD
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3727000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3727000	USD
CY2022Q1	us-gaap	Assets Assets	3044559000	USD
CY2021Q4	us-gaap	Assets Assets	2850623000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	56850000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	58116000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	251194000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	278770000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	57902000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	52181000	USD
CY2022Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	43728000	USD
CY2021Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	40831000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	100161000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	89410000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3723000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3760000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	513558000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	523068000	USD
CY2022Q1	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	152010000	USD
CY2021Q4	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	152883000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1207104000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1056515000	USD
CY2022Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	71602000	USD
CY2021Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	69308000	USD
CY2022Q1	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	28272000	USD
CY2021Q4	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	27135000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	1972546000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1828909000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58385000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55308000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58134000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55190000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	383181000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	369760000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	781290000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	733992000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3077000	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2944000	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	92939000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	83042000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1071590000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1020768000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	423000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	946000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1072013000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1021714000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3044559000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2850623000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	713445000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627253000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	555641000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	482186000	USD
CY2022Q1	ensg	Rent Costof Services RentCostofServices	35762000	USD
CY2021Q1	ensg	Rent Costof Services RentCostofServices	33456000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38256000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34273000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14676000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13659000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	644335000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	563574000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	69110000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	63679000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	2068000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1641000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-816000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	748000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2884000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-893000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	66226000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	62786000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16138000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12949000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	50088000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	49837000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-252000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	631000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	49206000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54667000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54192000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56871000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56891000	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1021714000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2768000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	5241000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	15000	USD
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0550
CY2022Q1	us-gaap	Dividends Dividends	3042000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5167000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9882000	USD
CY2022Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	26000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-252000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1072013000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	818227000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3880000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	3725000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0525
CY2021Q1	us-gaap	Dividends Dividends	2886000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4054000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	631000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1248000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	49206000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	875580000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	50088000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	49837000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14676000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13659000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	223000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	210000	USD
CY2022Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	124000	USD
CY2021Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	112000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	264000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2142000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2560000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5167000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4054000	USD
CY2022Q1	ensg	Gain Loss On Insurance Claims And Disposal Of Assets GainLossOnInsuranceClaimsAndDisposalOfAssets	-4054000	USD
CY2021Q1	ensg	Gain Loss On Insurance Claims And Disposal Of Assets GainLossOnInsuranceClaimsAndDisposalOfAssets	236000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14117000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15449000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-5452000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-1224000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3580000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4271000	USD
CY2022Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	7916000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	7440000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-162000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-133000	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	7801000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	7459000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1467000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2768000	USD
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-28989000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-34562000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10416000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	11791000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3031000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1737000	USD
CY2022Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4740000	USD
CY2021Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4615000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-11000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-167000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45874000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34294000	USD
CY2022Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	15838000	USD
CY2021Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	15334000	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	16400000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2022Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	17010000	USD
CY2021Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	0	USD
CY2022Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	400000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	250000	USD
CY2022Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	431000	USD
CY2021Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	6250000	USD
CY2022Q1	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
CY2021Q1	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	840000	USD
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2340000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	6869000	USD
CY2022Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2553000	USD
CY2021Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	3430000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-764000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	279000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48240000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12212000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	979000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	849000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2768000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3880000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9882000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	3035000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2868000	USD
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2021Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1248000	USD
CY2022Q1	ensg	Purchases Of Non Controlling Interest PurchasesOfNonControllingInterest	26000	USD
CY2021Q1	ensg	Purchases Of Non Controlling Interest PurchasesOfNonControllingInterest	0	USD
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	120000	USD
CY2021Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2022Q1	ensg	Proceeds From Cares Act Provider Relief Funds And Medicare Advance Payment Program ProceedsFromCARESActProviderReliefFundsAndMedicareAdvancePaymentProgram	0	USD
CY2021Q1	ensg	Proceeds From Cares Act Provider Relief Funds And Medicare Advance Payment Program ProceedsFromCARESActProviderReliefFundsAndMedicareAdvancePaymentProgram	9139000	USD
CY2022Q1	ensg	Coronavirus Aid Relief And Economic Security Cares Funds Repaid CoronavirusAidReliefAndEconomicSecurityCARESFundsRepaid	0	USD
CY2021Q1	ensg	Coronavirus Aid Relief And Economic Security Cares Funds Repaid CoronavirusAidReliefAndEconomicSecurityCARESFundsRepaid	111162000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11289000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-103117000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13655000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-81035000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	262201000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	236562000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	248546000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	155527000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2107000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1427000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	35972000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	33339000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3900000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3800000	USD
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3042000	USD
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2886000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	170007000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37471000	USD
CY2022Q1	ensg	Number Of Health Care Facilities NumberOfHealthCareFacilities	250	facility
CY2022Q1	ensg	Operational Skilled Nursing Beds OperationalSkilledNursingBeds	25500	bed
CY2022Q1	ensg	Operational Senior Living Units OperationalSeniorLivingUnits	2700	seniorLivingUnit
CY2022Q1	ensg	Number Of Real Estate Properties Leased NumberOfRealEstatePropertiesLeased	179	facility
CY2022Q1	ensg	Number Of Real Estate Properties Leased With Option To Purchase NumberOfRealEstatePropertiesLeasedWithOptionToPurchase	11	facility
CY2022Q1	ensg	Number Of Real Estate Properties Leased NumberOfRealEstatePropertiesLeased	179	facility
CY2022Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	102	facility
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> — </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period results reflect reclassifications, for comparative purposes, related to the change in the Company's segment structure as a result of the formation of Standard Bearer. Refer to Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments</span>, for additional information related to segments.
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> —</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the Interim Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company’s Interim Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use assets, impairment of long-lived assets, lease liabilities, general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities, and income taxes. Actual results could differ from those estimates.</span>
CY2022Q1	ensg	Liabilities Deferred Tax Payments Under Cares Act Noncurrent LiabilitiesDeferredTaxPaymentsUnderCARESActNoncurrent	24155000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2021Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2022Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2022Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2021Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2021Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2022Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	7206000	USD
CY2021Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	6755000	USD
CY2021Q4	ensg	Liabilities Deferred Tax Payments Under Cares Act Current LiabilitiesDeferredTaxPaymentsUnderCARESActCurrent	24154000	USD
CY2022Q1	ensg	Coronavirus Aid Relief And Economic Security Cares Funds Received And Returned CoronavirusAidReliefAndEconomicSecurityCARESFundsReceivedAndReturned	0	USD
CY2021Q1	ensg	Coronavirus Aid Relief And Economic Security Cares Funds Received And Returned CoronavirusAidReliefAndEconomicSecurityCARESFundsReceivedAndReturned	9139000	USD
CY2020	ensg	Medicare Accelerated And Advance Payment Caresact MedicareAcceleratedAndAdvancePaymentCARESACT	105255000	USD
CY2020	ensg	Repayment Of Funds Received From The Medicare Accelerated And Advance Payment Program Cares Act RepaymentOfFundsReceivedFromTheMedicareAcceleratedAndAdvancePaymentProgramCARESAct	3232000	USD
CY2021Q1	ensg	Repayment Of Funds Received From The Medicare Accelerated And Advance Payment Program Cares Act RepaymentOfFundsReceivedFromTheMedicareAcceleratedAndAdvancePaymentProgramCARESAct	102023000	USD
CY2022Q1	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1499000	USD
CY2021Q4	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1781000	USD
CY2022Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	17317000	USD
CY2021Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	15645000	USD
CY2022Q1	ensg	Revenue Recognition Family First Coronavirus Response Act Revenue Recognized RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized	17599000	USD
CY2021Q1	ensg	Revenue Recognition Family First Coronavirus Response Act Revenue Recognized RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized	16465000	USD
CY2020Q4	ensg	Liabilities Deferred Tax Payments Under Cares Act LiabilitiesDeferredTaxPaymentsUnderCARESAct	48309000	USD
CY2022Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	353098000	USD
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	339944000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13212000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11213000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	339886000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	328731000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	50088000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	49837000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-252000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	631000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	49206000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54667000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54192000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	50088000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	49837000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-252000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	631000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	49206000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54667000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54192000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2204000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2699000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56871000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56891000	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	647000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28000	shares
CY2022Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	102	facility
CY2022Q1	ensg	Number Of Lease Arrangements NumberOfLeaseArrangements	5	lease
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q1	ensg	Skilled Service Facilities SkilledServiceFacilities	217	facility
CY2022Q1	ensg	Skilled Services And Senior Living Campuses SkilledServicesAndSeniorLivingCampuses	23	facility
CY2022Q1	ensg	Senior Living Facilities SeniorLivingFacilities	10	facility
CY2022Q1	ensg	Skilled Services And Senior Living Campuses SkilledServicesAndSeniorLivingCampuses	23	facility
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	713445000	USD
CY2022Q1	ensg	Segment Income Loss SegmentIncomeLoss	66226000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14676000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	2068000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627253000	USD
CY2021Q1	ensg	Segment Income Loss SegmentIncomeLoss	62346000	USD
CY2021Q1	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	440000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	62786000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13659000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	1641000	USD
CY2022Q1	ensg	Payments To Acquire Business And Asset Acquisitions PaymentsToAcquireBusinessAndAssetAcquisitions	33410000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1216647000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1184201000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	309870000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	295767000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	906777000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	888434000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5511000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2846000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2665000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5383000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2731000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2652000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	404000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	247000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	234000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	234000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	234000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	234000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	234000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1248000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2665000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	60469000	USD
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	16400000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	76869000	USD
CY2022Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3727000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3727000	USD
CY2022Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	1776000	USD
CY2021Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	1953000	USD
CY2022Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	7206000	USD
CY2021Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	6755000	USD
CY2022Q1	us-gaap	Security Deposit SecurityDeposit	14429000	USD
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	13705000	USD
CY2022Q1	us-gaap	Other Restricted Assets OtherRestrictedAssets	6315000	USD
CY2021Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	7103000	USD
CY2022Q1	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	25446000	USD
CY2021Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	17530000	USD
CY2022Q1	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	55172000	USD
CY2021Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	47046000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1202000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3723000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3760000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	306000	USD
CY2022Q1	ensg	Investment Expense Income InvestmentExpenseIncome	-1211000	USD
CY2021Q1	ensg	Investment Expense Income InvestmentExpenseIncome	351000	USD
CY2022Q1	ensg	Quality Assurance Fee QualityAssuranceFee	6652000	USD
CY2021Q4	ensg	Quality Assurance Fee QualityAssuranceFee	6474000	USD
CY2022Q1	ensg	Resident Refunds Payable ResidentRefundsPayable	36074000	USD
CY2021Q4	ensg	Resident Refunds Payable ResidentRefundsPayable	34814000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6936000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9337000	USD
CY2022Q1	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1499000	USD
CY2021Q4	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1781000	USD
CY2022Q1	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	5952000	USD
CY2021Q4	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	6430000	USD
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3042000	USD
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3035000	USD
CY2022Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	7716000	USD
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	9124000	USD
CY2022Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	10416000	USD
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3626000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18248000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18415000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	100161000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	89410000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16138000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12949000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.244
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3255000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3324000	USD
CY2022Q1	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	152010000	USD
CY2021Q4	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	152883000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3723000	USD
CY2022Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	6710000	USD
CY2022Q1	ensg	Number Of Option Plans NumberOfOptionPlans	1	plan
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	164000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	164000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.423
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.003
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	136000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.422
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.002
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	164000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	79.79
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	33.56
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	136000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	83.64
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	33.99
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4038000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	36.60
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2183000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.02
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	164000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	79.79
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	31000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	52.39
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	147000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	18.86
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4024000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	38.89
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2172000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.57
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	4024000	shares
CY2022Q1	ensg	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Fair Value ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue	60053000	USD
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2172000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	205704000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	191242000	USD
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	146474000	USD
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	137382000	USD
CY2022Q1	ensg	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	53305000	USD
CY2021Q4	ensg	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	48548000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9502000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	17241000	USD
CY2022Q1	ensg	Sharebased Compensation Restricted Awards Exercise Price SharebasedCompensationRestrictedAwardsExercisePrice	0
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5167000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4054000	USD
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y
CY2022Q1	ensg	Facilities Under Master Lease Arrangement FacilitiesUnderMasterLeaseArrangement	44	facility
CY2022Q1	ensg	Master Lease Agreements MasterLeaseAgreements	8	agreement
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	41437000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	37209000	USD
CY2022Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	124000	USD
CY2021Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	112000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	106273000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	139958000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	138965000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	138854000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	138749000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	137931000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1224452000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2025182000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	760176000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1265006000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	57902000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1207104000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y2M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	4289000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	3977000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	12519000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	16380000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	15670000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	15275000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	15064000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	15064000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	81486000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	171458000	USD
CY2022Q1	ensg	Facilities Under Medicare Probe Reviews FacilitiesUnderMedicareProbeReviews	19	facility

Files In Submission

Name	View Source	Status
0001125376-22-000075-index-headers.html	Edgar Link	pending
0001125376-22-000075-index.html	Edgar Link	pending
0001125376-22-000075.txt	Edgar Link	pending
0001125376-22-000075-xbrl.zip	Edgar Link	pending
ensg-20220331.htm	Edgar Link	pending
ensg-20220331.xsd	Edgar Link	pending
ensg-20220331_cal.xml	Edgar Link	unprocessable
ensg-20220331_def.xml	Edgar Link	unprocessable
ensg-20220331_g1.jpg	Edgar Link	pending
ensg-20220331_htm.xml	Edgar Link	completed
ensg-20220331_lab.xml	Edgar Link	unprocessable
ensg-20220331_pre.xml	Edgar Link	unprocessable
ensgq12022ex311.htm	Edgar Link	pending
ensgq12022ex312.htm	Edgar Link	pending
ensgq12022ex321.htm	Edgar Link	pending
ensgq12022ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENSG
ENSIGN GROUP, INC Stock $ensg

2022 Q1 Form 10-Q Financial Statement

#000112537622000075 Filed on April 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG ENSIGN GROUP, INC Stock $ensg

2022 Q1 Form 10-Q Financial Statement

#000112537622000075 Filed on April 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG
ENSIGN GROUP, INC Stock $ensg